@article{3d3ddfdac0f34c0bbb9c480be868e8a6,
title = "End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19",
author = "Pebody, {Richard G.} and Heather Whitaker and Joanna Ellis and Nick Andrews and Marques, {Diogo F.P.} and Simon Cottrell and Reynolds, {Arlene J.} and Rory Gunson and Catherine Thompson and Monica Galiano and Angie Lackenby and Chris Robertson and O'Doherty, {Mark G.} and Katie Owens and Ivelina Yonova and Shepherd, {Samantha J.} and Catherine Moore and Jillian Johnston and Matthew Donati and Jim McMenamin and {de Lusignan}, Simon and Maria Zambon",
note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SdeL has received University funding for studies of post vaccination adverse events of interest from GSK, and for attitudes to vaccination from Seqirus; and has been a member of Seqirus and Sanofi advisory boards. MD received lecturing fee from Sanofi Pasteur MSD; SpeeDx provided partial financial support for an educational meeting and UK Clinical Virology Network (UK CVN) which he chairs is a registered charity which includes a number of commercial partners. CM has received funding as an advisory board member of Seqirus. No other co-authors had conflicts to declare. Funding Information: We are grateful to the many patients of participating practices who consent to virology swabs being taken; to the practices in the participating in the surveillance schemes in England, Wales, Northern Ireland and Scotland who supplied the clinical information on their patients; to the staff of the PHE Respiratory Virus Unit, the PHE Specialist Microbiology Laboratories, Public Health Wales Specialist Virology Centre, the West of Scotland Specialist Virology Centre and the Regional Virus Laboratory, Belfast who undertook analysis of specimens. We thank the staff of PHE, RCGP RSC, Public Health Wales, Public Health Agency Northern Ireland and Health Protection Scotland teams who coordinate the GP schemes, in particular Praveen SebastianPillai and Nisha Oppilamany from PHE; Malorie Perry, Richard Lewis, Ember Hilvers, and Caroline Harries from PHW; Emma Walker, Emma Dickson and Jeffrey Doogan from the PHA; Catherine Frew and Alasdair MacLean from WoSSVC and, Naoma William, Louise Primrose-Shaw, Karen Voy,and the Scottish Health Protection Network Project Team from HPS for overseeing data collection, and Filipa Ferreira, Rachel Byford, Sameera Pathirannehelage and Mariya Hriskova from RCGP RSC/University of Surrey. We acknowledge the originating and submitting laboratories of the sequences from GISAID's EpiFlu Database on which some of the analyses are based. All submitters of data may be contacted directly via the GISAID website www.gisaid.org. Publisher Copyright: {\textcopyright} 2019",
year = "2020",
month = jan,
day = "16",
doi = "10.1016/j.vaccine.2019.10.071",
language = "English",
volume = "38",
pages = "489--497",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "3",
}
